Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
LettersThis Week's LettersA reader advocates public openness in debates about genetically modified food. The Chief Scientific Officer at CaP CURE takes exception to characterizations of business events and CaP CURE founder Michael Milken. An EPA official defends the interdisciplinary nature of her agency's research. Credit is given to a pioneer in using Caenorhabditis elegans as a model metazoan organism in research. A central authority and an international regulating body are urged for P4 facilities around the world: "P4 facilities...should be considered with the same regard as nuclear weapon storage facilities." And the U.S. tradable emission permit system is said to be not a "free-market," but a "constructed-market," approach.
Letters in This IssueHow to Submit a Letter to the Editor
|
Science. ISSN 0036-8075 (print), 1095-9203 (online)